ZimVie (NASDAQ:ZIMV – Get Free Report) is one of 14 public companies in the “Dental equipment & supplies” industry, but how does it weigh in compared to its competitors? We will compare ZimVie to related companies based on the strength of its earnings, valuation, analyst recommendations, institutional ownership, profitability, risk and dividends.
Analyst Recommendations
This is a summary of current ratings and price targets for ZimVie and its competitors, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ZimVie | 1 | 0 | 0 | 0 | 1.00 |
| ZimVie Competitors | 96 | 189 | 244 | 0 | 2.28 |
ZimVie currently has a consensus target price of $11.00, indicating a potential upside of 33.82%. As a group, “Dental equipment & supplies” companies have a potential upside of 912.29%. Given ZimVie’s competitors stronger consensus rating and higher probable upside, analysts clearly believe ZimVie has less favorable growth aspects than its competitors.
Earnings & Valuation
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| ZimVie | $913.86 million | -$63.88 million | -2.60 |
| ZimVie Competitors | $1.52 billion | $10.99 million | 5.05 |
ZimVie’s competitors have higher revenue and earnings than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Volatility & Risk
ZimVie has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, ZimVie’s competitors have a beta of 1.15, suggesting that their average stock price is 15% more volatile than the S&P 500.
Profitability
This table compares ZimVie and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ZimVie | -9.27% | 3.80% | 1.76% |
| ZimVie Competitors | -52.05% | -59.77% | -16.61% |
Insider and Institutional Ownership
85.2% of ZimVie shares are owned by institutional investors. Comparatively, 49.9% of shares of all “Dental equipment & supplies” companies are owned by institutional investors. 3.0% of ZimVie shares are owned by company insiders. Comparatively, 27.9% of shares of all “Dental equipment & supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
ZimVie competitors beat ZimVie on 7 of the 12 factors compared.
ZimVie Company Profile
ZimVie Inc., a medical technology company, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; hardware and software solutions consist of intraoral scanners and RealGUIDE; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.
